EVER · EverQuote, Inc.

Current Thesis

EverQuote runs the online auto/home insurance lead-generation marketplace. The trade that worked through 2024–early-2025 was the carrier ad-spend recovery supercycle: insurers that gutted acquisition budgets in 2022–23 over loss-ratio pain came back hard, pushing total revenue +83% YoY in Q1'25 and the stock into the high-$20s. That leg has matured. Q1'26 (reported 2026-05-06) printed revenue $190.9M, up just +15% YoY, and the YoY growth curve has collapsed step by step: +83% (Q1'25) → +34% (Q2'25) → +20% (Q3'25) → +32% (Q4'25) → +15% (Q1'26). Sequentially the print has parked in a $190–195M band for three straight quarters. The stock bounced +36.6% off its trailing-four-week low into the post-earnings move, tagged ~$19.95 on 2026-06-02, and has already started fading ($19.32 close 2026-06-05) a recovery rally into resistance, capped under the 200-DMA (~$22.49). No accelerating narrative leg, and the next company catalyst (Q2 print 2026-08-10) sits well outside the 30-day window. This is a watch-only name for a momentum book.

Bull Case

• Record profitability, clean beat: Q1'26 revenue $190.9M (+15% YoY) vs guide $175–185M and consensus ~$180.1M; net income $18.7M; record adjusted EBITDA $29.3M (+30% YoY); operating cash flow $29.6M (8-K, 2026-05-06). This is a cash-generative marketplace, not a burner.
• Home/renters is the emergent growth thread: Q1'26 home & renters revenue $18.5M, +33% YoY vs auto's +13% the one line growing materially faster than the core. Management's stated arc is to grow home from ~10% of revenue toward its larger TAM, and it reiterated a $1B annual revenue goal within 2–3 years on the Q1 call (2026-05-06).
• Fortress balance sheet + float shrink: $178.5M cash, zero debt as of 2026-03-31, even after repurchasing $19.9M of stock in Q1'26.
• Easy Q2 comp: Q2'26 guide is revenue $185–195M (+21% YoY at midpoint), VMD $55–57M (+23%), adj EBITDA $28–30M (+32%) the +21% headline is flattered by a soft Q2'25 base, but it optically re-accelerates the growth line into the August print.
• Sell-side still constructive: consensus Buy (8 analysts, 100% Buy distribution), average PT $25.83, range $23–$30 roughly 30%+ above the $19.32 close.

Bear Case

• The narrative already paid out. YoY revenue growth fell from +83% (Q1'25) to +15% (Q1'26); the cyclical ad-spend snapback is largely spent and priced.
• Sequential revenue has flatlined near $190M for three quarters; Q1'26 ($190.9M) was actually down from Q4'25 ($195.3M), and the Q2 guide midpoint (~$190M) implies no sequential ramp.
• Broken long-term structure: the close ($19.32, 2026-06-05) sits below the 200-DMA (~$22.49). The round-trip from the high-$20s down to a $13.88 52-week low means overhead supply caps every rally into the low-$20s.
• the bullish case got smaller.
• No catalyst for 30+ days. Q2'26 prints 2026-08-10; nothing company-specific drives a momentum move in the window. The bounce is fading off the 2026-06-02 high, which is the more relevant near-term tell than the August setup.

Setup & Price Structure

• Last $19.32 (2026-06-05 close); +36.6% over the trailing four weeks, peaking ~$19.95 on 2026-06-02 before rolling over.
• 52-week range $13.88–$28.73 mid-range, leaning low. P/E ~6.6, market cap ~$683M.
• 50-DMA rising toward ~$17.50 (price above) / 200-DMA ~$22.49 (price below). The bounce reclaimed the 50-DMA off the low but stalled well under the 200-DMA the classic decelerating-name relief rally into structural resistance.
• Average daily volume has roughly doubled to ~747K (from ~328K earlier this spring) the post-earnings pop brought real tape, which at least eases the scaling problem if a clean trigger ever appears.
• The actionable momentum trigger is not here: it would be a high-volume reclaim and hold of the 200-DMA (~$22–23), which would flip the long-term structure and put the prior high-$20s back in play. Until then, strength is mean-reversion, not a new narrative leg.

Catalyst Calendar (next 30 days)

• No EverQuote-specific catalyst in window. Q2'26 earnings confirmed for 2026-08-10 outside 30 days; late-July/early-August becomes the relevant blackout/setup window, not now.
• Progressive (PGR) monthly metrics, ~mid-June 2026 (est.): PGR reports monthly results that proxy carrier ad-spend appetite the cleanest orthogonal read-through on whether the lead-gen demand cycle is holding or rolling.
• MediaAlpha (MAX) carries no scheduled print in window either; any unscheduled carrier-budget commentary from ALL/PGR is the only thing likely to move the cohort before August.

What Would Change Our Mind

• Bullish flip → momentum long: a high-volume daily close above the 200-DMA (~$22.49) that holds, ideally confirmed by MAX breaking out in sympathy (cluster confirmation) that turns the relief bounce into a structural re-rate and warrants a probe.
• Re-acceleration on fundamentals: Q2'26 print (2026-08-10) with VMD above the $57M guide high-end and a Q3 guide showing sequential revenue back above $195M would re-arm the growth narrative.
• Thesis fully broken: a daily close back below the rising 50-DMA (~$17.50) ends the post-earnings bounce and reverts price to the $14–17 base; or a Q2'26 VMD print below the $55M guide floor, signaling carrier ad-spend rollover rather than plateau.
• Home-vertical inflection: home & renters sustaining >30% YoY growth and crossing toward ~15%+ of revenue would justify re-tagging this from a spent cyclical to an emergent secular story.

Correlation Notes

• MediaAlpha (MAX) trades the same carrier-acquisition-spend cycle and is the primary cluster/divergence partner if a leg is real, both break out together; MAX failing to confirm a EVER move is a fade tell.
• Progressive (PGR), Allstate (ALL) are the upstream demand: their advertising/customer-acquisition budgets are the input variable for EVER's revenue. Their monthly metrics and ad-spend commentary lead EVER's print.
• Thin-float dynamics have eased somewhat (volume ~747K vs ~328K), but this remains a small-cap ($683M) name where a single carrier's budget shift swings the thesis position sizing must respect single-customer concentration risk.